Labiotech.eu

News and Trends 20 May 2021

EU Approves Edible Insects for Humans but Roadblocks Remain

Europe is seeing a surge of interest in edible insect farming after an EU vote earlier this month greenlit the first insect-derived food product for human consumption. But insect protein pioneers still face other obstacles such as restrictions on what insects can be fed. The approval went to dried yellow mealworm developed by French-based biotech […]

May 20, 2021 - 6 minutesmins - By Anita Chakraverty

Interview 19 May 2021

Are Biotech Startups Ready for Augmented Reality?

Augmented reality is starting to become a part of the manufacturing process of pharma and biotech companies. Paul Haimes, Vice President of Engineering at PTC, discusses the benefits and challenges to implementing this technology across the biotech industry. Augmented reality (AR) is increasingly being used to maintain and optimize biomanufacturing processes, which can bring economic […]

May 19, 2021 - 8 minutesmins - By Carlos de Rojas

carbios bioplastic avantium Industrial plant sustainability environment

News and Trends 18 May 2021

Avantium and Carbios Capitalize on Growing Bioplastics Demand

As the EU phases out a wide range of single-use plastics this year, investor interest is steadily increasing for adopting easily recyclable or bio-based plastics. In recent weeks, European biotechs Carbios and Avantium have taken big steps towards meeting rising demand. With millions of tons of plastic waste littering the ocean floors, truly solving our […]

May 18, 2021 - 5 minutesmins - By Victor Kotsev

Expert Advice 17 May 2021

How to Spend Your Biotech Startup’s Money

Biotech investment rounds tend to draw big headlines, but experienced players know the real work is done in between them. Avoiding some common pitfalls can make the difference between petering out and pressing on. Managing a biotech startup means always keeping an eye towards the next financing round. But piquing the next investor’s interest requires […]

May 17, 2021 - 6 minutesmins - By Mark Zipkin

News and Trends 11 May 2021

ADC Approval Buoys Spirits in Cancer Treatment Space

The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for blood cancer. This has given a major confidence boost to other European companies in the field as the deal mill picks up speed. Last month, ADC Therapeutics in Switzerland broke into the mainstream when its lead candidate Zynlonta received FDA […]

May 11, 2021 - 7 minutesmins - By Jonathan Smith

Interview 10 May 2021

The Rollercoaster of Repurposing an Arthritis Drug for Covid-19

The Covid-19 pandemic created an opportunity for many biotech companies to repurpose their existing programs into vaccines and treatments for the novel coronavirus. Cyxone’s CEO Tara Heitner and COO Malin Berthold discuss how they approached this shift at their company. Cyxone was founded in 2015 to develop drugs for rheumatoid arthritis and multiple sclerosis. Based […]

May 10, 2021 - 8 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 4 May 2021

Bluebird Bio Withdrawal Raises Gene Therapy Doubts in Europe

Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo in Germany after a pricing dispute with health authorities — a blow that could have repercussions for the rollout of other gene therapies in Europe. Zynteglo was approved in the EU in 2019 as the first-ever gene therapy for the […]

May 4, 2021 - 5 minutesmins - By Anita Chakraverty

medical cancer checkpoint inhibitor immunotherapy

News and Trends 29 Apr 2021

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel immune checkpoint target in nearly a decade. This could herald the next generation of checkpoint inhibitors against cancer. Last month, the antibody drug relatlimab, developed by Bristol Myers Squibb, increased the progression-free survival of melanoma patients in phase III. These […]

April 29, 2021 - 5 minutesmins - By Mark Zipkin

Sabine Dandiguian biotech company culture

Expert Advice 28 Apr 2021

How to Build a Successful Company Culture in Biotech

Company culture can be essential to the success of a biotech company. Sabine Dandiguian, Managing Partner at the life sciences VC firm Jeito Capital, shares her experience building a thriving company culture in the life sciences. Company culture is “something very special” that borders on collective intelligence, says Sabine Dandiguian. There are some basics to […]

April 28, 2021 - 8 minutesmins - By Victor Kotsev

multiple sclerosis novartis roche ema approval

News and Trends 27 Apr 2021

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations centered mostly on improving existing approaches. Which areas of multiple sclerosis treatment need more options? At the end of March, the EMA made key decisions on three treatments for multiple sclerosis (MS), a chronic neurodegenerative disease affecting 2.5 million people […]

April 27, 2021 - 6 minutesmins - By Jonathan Smith

Opinion 26 Apr 2021

How Good Investor Communications Determine Success in a Covid World

During the pandemic, the biotech industry has continued to complete deals, even without face-to-face interactions. Startups should leverage communication to sustain their investor relations and build strong momentum for late-stage funding rounds in the coming years. Speaking last July, the UK’s Secretary of State for Health and Social Care, Matt Hancock, said the Covid-19 pandemic […]

April 26, 2021 - 6 minutesmins - By External Contributor

Interview 21 Apr 2021

Changing Attitudes on Vaccine and Public Health Investment

The Covid-19 pandemic has pushed investment and research into vaccines and public health, but will such interest continue in the long term? Glenn Rockman, founder and Managing Partner of Adjuvant Capital, a VC firm investing in the infectious disease area, believes it will. Rockman did not plan to get into life science investment. With a […]

April 21, 2021 - 5 minutesmins - By Helen Albert

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

EU Approves Edible Insects for Humans but Roadblocks Remain

Are Biotech Startups Ready for Augmented Reality?

Avantium and Carbios Capitalize on Growing Bioplastics Demand

How to Spend Your Biotech Startup’s Money

ADC Approval Buoys Spirits in Cancer Treatment Space

The Rollercoaster of Repurposing an Arthritis Drug for Covid-19

Bluebird Bio Withdrawal Raises Gene Therapy Doubts in Europe

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

How to Build a Successful Company Culture in Biotech

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

How Good Investor Communications Determine Success in a Covid World

Changing Attitudes on Vaccine and Public Health Investment

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!